# Generic versions of Novo Nordisk's semaglutide are now available at lower prices.

*business · news · 2026-04-09 · The Economic Times*

## Key points

- Generic semaglutide captured 33% of India's GLP-1 market within days of launch in March.
- Mounjaro's market share in India dropped from 71% to 64% after generics entered.
- Torrent Pharmaceuticals now holds an 8% share in India's semaglutide market, second only to Novo Nordisk.
- Indian generics are priced as low as 1,290 rupees, over 85% cheaper than the original.
- Semaglutide drug volumes in India more than doubled in March compared to the previous month.

**Companies:** Eli Lilly & Co., Sun Pharmaceuticals, Dr Reddy’s Laboratories, Zydus Lifesciences, Natco Pharma, Eris Lifesciences, USV, Glenmark, Torrent Pharmaceuticals Ltd., Alkem Laboratories
**Countries:** India

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novo-nordisks-weight-loss-drug-patent-loss-sparks-a-gold-rush-for-generic-drugmakers/articleshow/130137051.cms)

---

Canonical: https://newsio.io/n/6b4fc937-9972-42a1-9405-3d481bfe1645/generic-versions-of-novo-nordisks-semaglutide-are-now-available-at-lower-prices
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works